Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $96.3400 (1.12%) ($94.8200 - $98.1000) on Mon. Feb. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.9% (three month average) | RSI | 64 | Latest Price | $96.3400(1.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.5% a day on average for past five trading days. | Weekly Trend | LGND advances 2.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -0.95% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) SHY(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.95% (StdDev 1.9%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
5 Day Moving Average | $93.3(3.26%) | 10 Day Moving Average | $91.26(5.57%) | 20 Day Moving Average | $90.65(6.28%) | To recent high | -14.7% | To recent low | 11.3% | Market Cap | $1.548b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |